Drug intelligence / Profile preview

human cord blood mononuclear cells

Development stage: Unknown
Lead developer: Beike Biotechnology
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous, Intrathecal

Overview

Human cord blood mononuclear cells (CBMNCs) developed by Shenzhen Beike Bio-Technology Co., Ltd. is an investigational cell therapy being evaluated for the treatment of autism spectrum disorder (ASD). The therapy consists of a heterogeneous population of cells isolated from human umbilical cord blood, including hematopoietic stem cells, endothelial progenitor cells, and mesenchymal stem cells. These cells are hypothesized to address the neural hypoperfusion and immune dysregulation associated with ASD by modulating immune responses, promoting angiogenesis, and potentially supporting neural repair. In clinical evaluations, CBMNCs have been administered via intravenous and intrathecal routes, often in conjunction with rehabilitation therapy or umbilical cord-derived mesenchymal stem cells (UCMSCs).

Other names: human umbilical cord blood mononuclear cells

Beyond the preview

Go deeper on human cord blood mononuclear cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on human cord blood mononuclear cells.

Explore the full profile